Drug Shortage Report for FASTURTEC
Report ID | 144133 |
Drug Identification Number | 02248416 |
Brand name | FASTURTEC |
Common or Proper name | Fasturtec |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | RASBURICASE |
Strength(s) | 1.5MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 3 |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-08-13 |
Actual start date | |
Estimated end date | 2021-08-27 |
Actual end date | 2021-08-26 |
Shortage status | Resolved |
Updated date | 2021-08-27 |
Company comments | Missing a quality document. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-08-27 | English | Compare |
v7 | 2021-08-26 | French | Compare |
v6 | 2021-08-26 | English | Compare |
v5 | 2021-08-17 | French | Compare |
v4 | 2021-08-17 | English | Compare |
v3 | 2021-08-14 | English | Compare |
v2 | 2021-08-13 | French | Compare |
v1 | 2021-08-13 | English | Compare |
Showing 1 to 8 of 8